Allyson S. Gilstrap, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 Brocks Gap Pkwy Ste 101, Hoover, AL 35244 Phone: 205-421-1032 Fax: 205-421-1040 |
Alex J Mcdonald, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2949 John Hawkins Pkwy, Hoover, AL 35244 Phone: 205-987-0005 Fax: 205-987-0065 |
Mary C Gipson, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 118 Mars Hill Rd, Hoover, AL 35244 Phone: 205-987-0005 Fax: 205-987-0065 |
Harveen Sodhi, MD Family Medicine - Adult Medicine Medicare: Accepting Medicare Assignments Practice Location: 5310 Medford Dr, Hoover, AL 35244 Phone: 205-820-8440 Fax: 205-820-8449 |
Dr. James Davis Blake, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3081 Lorna Rd, Suite 101, Hoover, AL 35216 Phone: 205-979-3381 |
Sumayah Abed, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 501 Emery Dr W, Hoover, AL 35244 Phone: 205-989-7254 |
Dr. Jody Edward Gilstrap, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 Brocks Gap Pkwy Ste 101, Hoover, AL 35244 Phone: 205-421-1032 Fax: 205-421-1040 |
News Archive
Long-time healthcare education business owner, Deborah Kann Schwarzberg, has established GlobalHealth Education & Training®, a corporate training and degree-granting educational service. GlobalHealth was formed to respond to the growing demand for trained employees and management within the healthcare and ancillary industries to enhance their formal education and attain advanced degrees online.
Novasys Medical, Inc., a developer of innovative therapies in women's health, announced today that its Renessa® non-surgical treatment for female stress urinary incontinence (SUI) was inducted into the Phoenix Hall of Fame as the 2009 Most Promising New Product at the Phoenix Medical Device and Diagnostic Conference for Chief Executive Officers.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that a Phase I study, called RV262, recently began to evaluate a combination DNA prime/MVA vector boost regimen that was developed to protect against diverse subtypes of HIV-1 prevalent in North America, Europe, Africa, and South America.
The research examined pancreatic cancer cells for tiny molecules called microRNA (miRNA). It shows that relative levels of certain miRNAs can distinguish pancreatic cancer from nearby noncancerous tissue and from inflamed pancreatic tissue.
› Verified 5 days ago